Aftab A. Ala

Denmark Hill
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Metabolic dysfunction-associated steatotic liver disease (MASLD) is under-recognised: Should hepatic elastography be integrated into early risk stratification for people with type 2 diabetes?

Metabolic dysfunction-associated steatotic liver disease (MASLD) is under-recognised: Should hepatic elastography be integrated into early risk stratification for people with type 2 diabetes?

Journal: Clinical medicine (London, England)

Published: July 20, 2026

Can hepatology lead the way? Synthesising current global curricula and proposing a model for an international specialty curriculum.

Can hepatology lead the way? Synthesising current global curricula and proposing a model for an international specialty curriculum.

Journal: Clinical medicine (London, England)

Published: March 04, 2026

Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial.

Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial.

Journal: Hepatology communications

Published: February 09, 2026

Rethinking coeliac disease care: why psychological understanding matters.

Rethinking coeliac disease care: why psychological understanding matters.

Journal: The lancet. Gastroenterology & hepatology

Published: January 20, 2026

Challenging times in medical education in the era of artificial intelligence can provide opportunities.

Challenging times in medical education in the era of artificial intelligence can provide opportunities.

Journal: Clinical medicine (London, England)

Published: November 22, 2025

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson disease.

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson disease.

Journal: JHEP reports : innovation in hepatology

Published: September 22, 2025

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.

Journal: JHEP reports : innovation in hepatology

Published: September 22, 2025

Rare but relevant: Genetic liver disease in the general medical setting.

Rare but relevant: Genetic liver disease in the general medical setting.

Journal: Clinical medicine (London, England)

Published: September 03, 2025

Oral bis-choline tetrathiomolybdate rapidly improves copper balance in patients with Wilson disease.

Oral bis-choline tetrathiomolybdate rapidly improves copper balance in patients with Wilson disease.

Journal: Journal of hepatology

Published: July 04, 2025

Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group.

Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group.

Journal: Orphanet journal of rare diseases

Published: June 10, 2025

Harnessing faith-based organisations for global health equity.

Harnessing faith-based organisations for global health equity.

Journal: Lancet (London, England)

Published: November 13, 2024

Building Clinical and Research Delivery Networks: A Blue Print for Multidisciplinary Management and Consensus in Wilson Disease.

Building Clinical and Research Delivery Networks: A Blue Print for Multidisciplinary Management and Consensus in Wilson Disease.

Journal: GE Portuguese journal of gastroenterology

Published: October 20, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026